A detailed history of Wolff Wiese Magana LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 103 shares of NBIX stock, worth $14,062. This represents 0.01% of its overall portfolio holdings.

Number of Shares
103
Previous 47 119.15%
Holding current value
$14,062
Previous $6,000 83.33%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$114.58 - $153.15 $6,416 - $8,576
56 Added 119.15%
103 $11,000
Q2 2024

Jul 12, 2024

SELL
$130.86 - $143.19 $3,402 - $3,722
-26 Reduced 35.62%
47 $6,000
Q1 2024

Apr 18, 2024

BUY
$130.4 - $143.74 $3,390 - $3,737
26 Added 55.32%
73 $10,000
Q3 2023

Oct 30, 2023

SELL
$94.02 - $117.1 $9,402 - $11,710
-100 Reduced 68.03%
47 $5,000
Q1 2021

Apr 15, 2021

BUY
$87.57 - $119.4 $2,189 - $2,985
25 Added 20.49%
147 $14,000
Q4 2020

Jan 27, 2021

BUY
$86.91 - $108.33 $10,603 - $13,216
122 New
122 $12,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.